Transactions: Sweden
Filter
Private placement of equity in BioInvent International AB (SE) — SEK 194 million
Merger of Life Science Department of 6-AP Fund (SE) with Medicon Valley Capital (DK) and Innoventus (SE) — SEK 1.7 billion
Public offer for Gambro (SE) by Investor (SE) and EQT (SE) — SEK 39 billion
Divestment of Proxima (SE) to Aleris (SE) by CapMan (FI) — SEK 1.1 billion
Secondary placing of shares in Alliance Oil (SE) — SEK 1.2 billion
Acquisition of Nordic Modular Group (SE) by Kungsleden AB (publ) (SE) from 3i Group plc (UK) — SEK 918 million
Acquisition of Personal Chemistry (SE) by Pyrosequencing (SE) — Amount not disclosed.
Bond issue by Hemsö Fastighets AB (SE) — SEK 750 million
Divestment of Semper Clinical Nutrition business unit (SE) to Novartis (CH) by Arla Foods (SE) — Amount not disclosed.
Directed issue of preference shares in Sagax (SE) — SEK 376 million